Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine

Unknown 40 enrolled Hospital Universitário Professor Edgard Santos

RandomizedParallel-groupSingle-blindBasic science

Summary

This study is designed to evaluate the immune and therapeutic responses of visceral leishmaniasis patients using N-acetylcysteine (NAC) as an adjuvant therapy to pentavalent antimony.

Timeline

Start: 2010-04
Primary completion: 2011-06
Completion: 2011-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	N-acetylcysteine	Small molecule	600 mg	Oral

Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine

Summary

Timeline

Drugs

Indications